Centessa Pharmaceuticals Ltd (40) | Contribution Agreements (10)
Recent Contracts
-
Contribution agreement, dated January 23, 2021, by and between ApcinteX Limited, United Medicines Biopharma Limited and the other parties thereto
(Filed With SEC on April 21, 2021)
-
Contribution agreement, dated January 23, 2021, by and between Capella Bioscience LTD, United Medicines Biopharma Limited and the other parties thereto
(Filed With SEC on April 21, 2021)
-
Contribution agreement, dated January 23, 2021, by and between Inexia Limited, United Medicines Biopharma Limited and the other parties thereto
(Filed With SEC on April 21, 2021)
-
Contribution agreement, dated January 23, 2021, by and between Janpix Limited, United Medicines Biopharma Limited and the other parties thereto
(Filed With SEC on April 21, 2021)
-
Contribution agreement, dated January 23, 2021, by and between LockBody Therapeutics Ltd, United Medicines Biopharma Limited and the other parties thereto
(Filed With SEC on April 21, 2021)
-
Contribution agreement, dated January 23, 2021, by and between Morphogen-IX Limited, United Medicines Biopharma Limited and the other parties thereto
(Filed With SEC on April 21, 2021)
-
Contribution agreement, dated January 23, 2021, by and between Orexia Limited, United Medicines Biopharma Limited and the other parties thereto
(Filed With SEC on April 21, 2021)
-
Contribution agreement, dated January 23, 2021, by and between Z Factor Limited, United Medicines Biopharma Limited and the other parties thereto
(Filed With SEC on April 21, 2021)
-
Contribution Agreement, dated January 23, 2020, by and between Pega-One, United Medicines Biopharma Limited and the other parties thereto
(Filed With SEC on April 21, 2021)
-
Contribution Agreement, dated December 31, 2020 (as amended), by and between PearlRiver Bio GmbH, United Medicines Biopharma Limited, and the other parties thereto
(Filed With SEC on April 21, 2021)
